Page 1 of Clinical Trials for Drug gefitinib only, 162 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)
Last Updated: September 15, 2011
Condition(s): Lung Cancer
2
Active, not recruiting
High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations
Last Updated: November 3, 2009
Condition(s): Non-small Cell Lung Cancer
3
Recruiting
A Study of IRESSA Treatment Beyond Progression in Addition to Chemotherapy Versus Chemotherapy Alone
Last Updated: May 11, 2012
Condition(s): Non-Small Cell Lung Cancer
4
Completed
Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer
Last Updated: May 2, 2011
Condition(s): Lung Cancer
5
Recruiting
A Study of Alimta/Cisplatin/Gefitnib for Asian Non-smoking Patients With Non Small Cell Lung Cancer
Last Updated: May 18, 2012
Condition(s): Non Small Cell Lung Cancer
6
Active, not recruiting
LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib
Last Updated: May 2, 2012
Condition(s): Carcinoma, Non-Small-Cell Lung
7
Recruiting
Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung Cancer
Last Updated: December 22, 2011
Condition(s): Non Small Cell Lung Cancer (NSCLC)
8
Active, not recruiting
Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer
Last Updated: June 21, 2008
Condition(s): Brain and Central Nervous System Tumors; Prostate Cancer
9
Completed
Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer
Last Updated: February 26, 2011
Condition(s): Lung Cancer
10
Terminated
Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib
Last Updated: November 8, 2011
Condition(s): Lung Cancer
11
Not yet recruiting
Iressa Re-Challenge in Advanced NSCLC EGFR M+ Patients Who Responded to Gefitinib USed as 1st Line or Previous Treatment
Last Updated: May 18, 2012
Condition(s): Lung Cancer
12
Active, not recruiting
A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer
Last Updated: April 11, 2012
Condition(s): Carcinoma, Non-Small Cell-Lung; Lung Neoplasms; Lung Cancer; Respiratory Tract Neoplasms
13
Active, not recruiting
Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck Cancer
Last Updated: August 18, 2010
Condition(s): Head and Neck Cancer
14
Recruiting
Genius Study Study to Compare Efficacy and Safety of Gefitinib/ Pemetrexed With Pemetrexed Alone as Maintenance Therapy in Patients With Stage IV EGFR Mutation Negative or T790M Single Mutation Who Respond to Pemetrexed/ Platinum as First-line Therapy
Last Updated: April 17, 2012
Condition(s): NSCLC
15
Completed
Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLC
Last Updated: December 5, 2011
Condition(s): LUNG CANCER
16
Recruiting
Hydroxychloroquine and Gefitinib to Treat Lung Cancer
Last Updated: March 27, 2012
Condition(s): Non-small Cell Lung Cancer
17
Completed
A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer
Last Updated: September 1, 2005
Condition(s): Lung Cancer
18
Recruiting
Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Last Updated: August 3, 2010
Condition(s): Lung Cancer
19
Active, not recruiting
Efficacy, Safety, Tolerability of Gefitinib as 1st Line in Caucasian Patients With EGFR Mutation Positive Advanced NSCLC
Last Updated: March 21, 2012
Condition(s): Caucasian Patients With EGFR Mutation Positive Advanced NSCLC
20
Recruiting
Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone
Last Updated: January 16, 2012
Condition(s): Non Small Cell Lung Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+gefitinib+only

Page 1 of Clinical Trials for Drug gefitinib only, 162 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About